Atlas Trials

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

Clinical trial NCT04378881 · UNKNOWN

Trial details

NCT number
NCT04378881
Sponsor
Tabula Rasa HealthCare
Status
UNKNOWN
Study type
OBSERVATIONAL
COVIDDrug EffectDrug InteractionAdverse Drug Event
Start date
2020-06-12
Primary completion
2023-06-11
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.